Economic Observation Network On October 9th, Huitianfu (589120), a science and technology innovation drug ETF, had a net subscription of 39 million shares, accounting for 2.82% of the ETF fund shares. The latest shares of the fund are 1.383 billion, with a cumulative increase of 1.042 billion shares since its listing. The latest scale is 1.085 billion yuan, and the cumulative increase since listing is 752 million yuan.

The fund has fallen 11.20% in the past year, with a maximum drawdown of 27.0%. The current ETF yield is 0.15%, exceeding the historical 69%, and it is in the medium risk zone. It is recommended to closely monitor the trend of the premium rate and market changes.

The above content is based on publicly available information and does not constitute investment advice.